Search research articles
Contact Us
Filters
Showing results (21-30 of 46) with videos related to
Page
of 5
Sort By:
Human Pathology
|
November 17, 2009
HER-2 amplification is highly homogenous in gastric cancer
Michael Bilous, Robert Y Osamura, J Rüschoff, et al.
American Journal of Clinical Pathology
|
September 19, 2009
Emerging technologies for assessing HER2 amplification
Frédérique Penault-Llorca, Michael Bilous, Mitch Dowsett, et al.
Asia-Pacific Journal of Clinical Oncology
|
December 24, 2016
Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study
Nirmala Pathmanathan, Jing-Shu Geng, Wencai Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 7, 2012
HER2 testing in gastric cancer: a practical approach
Josef Rüschoff, Wedad Hanna, Michael Bilous, et al.
Pathology
|
October 14, 2003
Supporting the implementation of breast pathology recommendations: feasibility of a feedback mechanism to pathologists
Maria I Torres, Fleur B Webster, A Michael Bilous, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 25, 2008
Re: High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system
Wedad M Hanna, Elizabeth Hammond, Clive R Taylor, et al.
Pathology
|
August 28, 2016
Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program
Adrienne L Morey, Belinda Brown, Gelareh Farshid, et al.
Pathology
|
August 22, 2017
HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program
M Priyanthi Kumarasinghe, Adrienne Morey, Michael Bilous, et al.
Pathology
|
December 23, 2009
A class discovery and class prediction approach to histopathological classification of mammographic screen detected columnar cell lesions of the breast
Nirmala Pathmanathan, Elizabeth L Salisbury, Pamela J Provan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 18, 2010
Diagnostic evaluation of papillary lesions of the breast on core biopsy
Nirmala Pathmanathan, Ann-Flore Albertini, Pamela J Provan, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 46) with videos related to
Sort By:
Page
of 5
Human Pathology
|
November 17, 2009
HER-2 amplification is highly homogenous in gastric cancer
Michael Bilous, Robert Y Osamura, J Rüschoff, et al.
American Journal of Clinical Pathology
|
September 19, 2009
Emerging technologies for assessing HER2 amplification
Frédérique Penault-Llorca, Michael Bilous, Mitch Dowsett, et al.
Asia-Pacific Journal of Clinical Oncology
|
December 24, 2016
Human epidermal growth factor receptor 2 status of gastric cancer patients in Asia: results from a large, multicountry study
Nirmala Pathmanathan, Jing-Shu Geng, Wencai Li, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
January 7, 2012
HER2 testing in gastric cancer: a practical approach
Josef Rüschoff, Wedad Hanna, Michael Bilous, et al.
Pathology
|
October 14, 2003
Supporting the implementation of breast pathology recommendations: feasibility of a feedback mechanism to pathologists
Maria I Torres, Fleur B Webster, A Michael Bilous, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 25, 2008
Re: High concordance between immunohistochemistry and fluorescence in situ hybridization testing for HER2 status in breast cancer requires a normalized IHC scoring system
Wedad M Hanna, Elizabeth Hammond, Clive R Taylor, et al.
Pathology
|
August 28, 2016
Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program
Adrienne L Morey, Belinda Brown, Gelareh Farshid, et al.
Pathology
|
August 22, 2017
HER2 testing in advanced gastric and gastro-oesophageal cancer: analysis of an Australia-wide testing program
M Priyanthi Kumarasinghe, Adrienne Morey, Michael Bilous, et al.
Pathology
|
December 23, 2009
A class discovery and class prediction approach to histopathological classification of mammographic screen detected columnar cell lesions of the breast
Nirmala Pathmanathan, Elizabeth L Salisbury, Pamela J Provan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 18, 2010
Diagnostic evaluation of papillary lesions of the breast on core biopsy
Nirmala Pathmanathan, Ann-Flore Albertini, Pamela J Provan, et al.
Page
of 5